Your browser doesn't support javascript.
loading
Long-term outcome of diffuse large B-cell lymphoma: Impact of biosimilar rituximab and radiation.
Ganesan, P; Sagar, T G; Kannan, K; Radhakrishnan, V; Rajaraman, S; John, A; Sundersingh, S; Mahajan, V; Ganesan, T S.
Afiliação
  • Ganesan P; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India.
  • Sagar TG; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India.
  • Kannan K; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India.
  • Radhakrishnan V; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India.
  • Rajaraman S; Department of Cancer Registry Registry and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India.
  • John A; Department of Radiation Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India.
  • Sundersingh S; Department of Pathology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India.
  • Mahajan V; Department of Radiology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India.
  • Ganesan TS; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India.
Indian J Cancer ; 54(2): 430-435, 2017.
Article em En | MEDLINE | ID: mdl-29469072
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioterapia / Linfoma Difuso de Grandes Células B / Medicamentos Biossimilares / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Indian J Cancer Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioterapia / Linfoma Difuso de Grandes Células B / Medicamentos Biossimilares / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Indian J Cancer Ano de publicação: 2017 Tipo de documento: Article